首页 › 基金 › Champlain Investment Partners, LLC › RGEN

Champlain Investment Partners, LLC 对 RGEN 的持仓历史

Repligen Corp · 医疗保健

Champlain Investment Partners, LLC 在 Q3 2026 的 13F 申报中披露持有 RGEN(Repligen Corp)249,195 股,市值约 US$47.9M,约占其申报组合的 1.65%,在其申报持仓中市值排名第 5 位。 Champlain Investment Partners, LLC 最近 13 个申报季度中有 13 个季度披露了 RGEN 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)249.19K 股
申报持仓市值$47.90M
组合权重1.65%
首次申报Q3 2023
最近变动减持
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

Champlain Investment Partners, LLC 对 RGEN 的持仓演变

Champlain Investment Partners, LLC 于 Q3 2023 首次披露 RGEN 持仓:855,190 股(约 US$136.0M)。 该持仓在 Q4 2024 达到峰值 1,543,530 股,市值约 US$222.2M。 在 13 次申报中,Champlain Investment Partners, LLC 3 次增持、9 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 249,195 股、市值约 US$47.9M,环比减持 -69,760 股。。 持仓曾出现大幅变动:Q1 2024 减持约 38% (随后一个季度股价下跌 31%)、Q3 2024 增持约 149% (随后一个季度股价下跌 3%)、Q2 2026 减持约 54% (随后一个季度股价上涨 41%)。

逐季持仓明细

季度股数金额变化
Q3 2023 855.19K $135.98M 新进
Q4 2023 926.44K $166.57M 增持
Q1 2024 575.00K $105.75M 减持
Q2 2024 570.59K $71.93M 减持
Q3 2024 1.42M $211.46M 增持
Q4 2024 1.54M $222.18M 增持
Q1 2025 1.46M $186.28M 减持
Q2 2025 1.40M $174.27M 减持
Q3 2025 1.34M $179.02M 减持
Q4 2025 1.00M $164.51M 减持
Q1 2026 693.86K $81.75M 减持
Q2 2026 318.95K $43.52M 减持
Q3 2026 249.19K $47.90M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 RGEN 与 13F 数据

RGEN(Repligen Corp)属于医疗保健行业。我们追踪的基金中还有 33 只申报持有 RGEN,申报仓位最大的包括:UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$536.3M), Maverick 资本 (US$270.8M), MAVERICK CAPITAL LTD (US$270.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 RGEN 的基金

查看 RGEN 的全部基金持有人 →

常见问题

How long has Champlain Investment Partners, LLC held RGEN?

Champlain Investment Partners, LLC has disclosed RGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Champlain Investment Partners, LLC's current position in RGEN?

As of Q3 2026, Champlain Investment Partners, LLC holds 249.19K shares of RGEN (Repligen Corp), valued at $47.90M, representing 1.65% of its reported portfolio and ranking #5.

Has Champlain Investment Partners, LLC been buying or selling RGEN?

In the latest 13F filing (Q3 2026), Champlain Investment Partners, LLC reduced its position in RGEN. The position peaked in Q4 2024 at 1.54M shares.

Which other funds hold RGEN?

Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick 资本, MAVERICK CAPITAL LTD, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.